Tate & Lyle has announced the appointment of Vivid Sehgal as its new chief financial officer, effective 1 May 2021.
Sehgal succeeds Imran Nawaz, who stepped down from the role last year.
He will step in as chief financial officer designate, and join the company’s board of directors on 1 March 2021.
Over the following months, he will work with Nawaz to ensure a smooth transition into the role.
Tate & Lyle chief executive Nick Hampton welcomed Sehgal and added, ”He [Sehgal] brings with him a proven track record of financial leadership as well as extensive commercial and transactional experience.
“I very much look forward to working with him as we continue to progress Tate & Lyle’s growth agenda.”
Sehgal is an experienced professional who served as the chief financial officer of automotive propulsion technology company Delphi Technologies PLC from 2017 to 2020.
Before this, he was the finance chief of LivaNova PLC, a global medical technology company.
Earlier in his career, he also held senior management positions in Allergan Inc., Gillette Inc., and GlaxoSmithKline PLC in the US, Europe, and the Middle East.
Tate & Lyle chairman, Gerry Murphy, commented, “Vivid’s broad financial, business and international experience will be of great value to Tate & Lyle and he is a very welcome addition to our board.”